|
Zrnith- Exempt Distribution
|
1
|
Zenith Epigenetics
|
Apr 01, 2022 09:58AM
|
|
ZHCLF
|
1
|
Zenith Epigenetics
|
Jul 21, 2022 09:42AM
|
|
ZHCLF
|
1
|
Zenith Epigenetics
|
Jan 03, 2024 11:19AM
|
|
ZHCLF
|
1
|
Zenith Epigenetics
|
Mar 12, 2021 10:58AM
|
|
Zenith-Oncology Pipeline
|
6
|
Zenith Epigenetics
|
Mar 16, 2021 08:18AM
|
|
Zenith shares
|
4
|
Zenith Epigenetics
|
Nov 04, 2019 10:57AM
|
|
Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
2
|
Zenith Epigenetics
|
Sep 24, 2024 07:56AM
|
|
Zenith Capital Corp a Private Company
|
4
|
Resverlogix Corp.
|
Aug 01, 2024 06:39PM
|
|
Zenith - Exempt Distribution
|
5
|
Zenith Epigenetics
|
Apr 01, 2022 10:46AM
|
|
ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
2
|
Zenith Epigenetics
|
Aug 27, 2021 12:56PM
|
|
Zacks BTI Valuation
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jul 29, 2022 06:57AM
|
|
Zacks
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2021 03:54PM
|
|
xB3-001 partnership
|
3
|
BIOASIS TECHNOLOGIES INC
|
Dec 11, 2020 09:28AM
|
|
What's up?
|
4
|
Resverlogix Corp.
|
May 24, 2023 11:50AM
|
|
What Is Peritoneal Carcinomatosis?
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 12:51PM
|
|
We need a major cash infusion to stay in business!
|
1
|
Resverlogix Corp.
|
Dec 23, 2022 08:46AM
|
|
Warrants: RVX.WT.A
|
3
|
Resverlogix Corp.
|
Apr 10, 2023 01:01PM
|
|
Warrants RVX.WT.A
|
1
|
Resverlogix Corp.
|
Jun 07, 2019 09:38AM
|
|
Warrants back in favour?
|
2
|
Resverlogix Corp.
|
Feb 10, 2022 10:30AM
|
|
Warrants
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 25, 2019 09:04AM
|
